Skip to main content

Part of UT Health San Antonio

Profiles - UT Health San AntonioProfiles - UT Health Science Center San Antonio

Part of UT Health San Antonio

Menu
  • Home

You are here

  • Profiles Home
  • Faculty Directory
  • Lathrop, Kate Ida
Kate Lathrop, M.D.

Contact

210-450-1000

lathrop@uthscsa.edu

Departments & Divisions

  • Department of Medicine
  • Division of Hematology & Oncology

Institutes & Centers

  • Mays Cancer Center

Kate I Lathrop, MD

Associate Professor/Clinical

Program Director, Medical Oncology and Hematology Fellowship Program

Assistant Dean of Undergraduate Research, Long School of Medicine

  • Professional Background

    Education

    • 2014 - Clinical Fellowship - Medical Oncology and Hematology - University of Texas Health Science Center at San Antonio
    • 2011 - Residency - Chief Resident - University of Texas Health Science Center at San Antonio, San Antonio, TX
    • 2010 - Residency - Internal Medicine - University of Texas Health Science Center at San Antonio
    • 2008 - Postdoctoral Training - Internal Medicine - University of Texas Health Science Center at San Antonio
    • 2007 - MD - Medicine - University of Texas Health Science Center at San Antonio
    • 2002 - BA - Biology - Colorado College

    Appointments

    • 7/2017 - Program Director Hematology Oncology Fellowship Program - UT Health San Antonio MD Anderson Cancer Center, Medicine, San Antonio
    • 8/2015 - Medical Director Hematology Oncology - University Health SystemSan Antonio
    • 8/2014 - Assistant Professor - UT Health San Antonio MD Anderson Cancer Center, Medicine, San Antonio
  • Instruction & Training

    • 9/2013 - Present, "True Stories" in Hematological and Oncoloical Emergencies:Internal Medicine Boot Camp, University of Texas Health Sciene Center at San Antonio
  • Research & Grants

    Breast Cancer, Clinical Trials

    Cancer Development and Progression Program 

  • Publications

      Abstract

      Lathrop KI. A phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer (MBC) who have received prior HER2 regimens for MBC; 2016 Dec. Lathrop KI. Adequacy of breast screening in women previously treated with chest wall radiation for lymphoma; 2016 Nov. Lathrop KI. 2017 Cancer Survivorship Symposium; 2016 Nov. Lathrop KI. Ribociclib (LEE011) and Letrozole in ER+, HER2- Advanced Breast Cancer: Phase lb Safety, Preliminary Efficacy, and Molecular Analysis"; 2016 Sep. Lathrop KI;Juric D, Ismail-Khan R, Campone M, Garcia-Estevez L, Becerra C, De Boer R, Hamilton E, Mayer IA, Hui R, Lathrop KI, Pagani O, Asano S, Bhansali SG, Zhang V, Hewes B, Munster P. [P3-14-01] Phase Ib/II study of ribociclib and alpelisib and letrozole in ER , HER2? breast cancer: Safety, preliminary efficacy and molecular analysis: Kate Lathrop; 2015 Dec.

      Editorial

      Lathrop KI. Highlights from 2015 San Antonio Breast Cancer Symposium Highlights from 2015 San Antonio Breast Cancer Symposium 2015 Dec;:1-20.

      Journal Article

      Parsons HM, Lathrop KI, Schmidt S, Mazo-Canola M, Trevino-Jones J, Speck H, Karnad AB. Breast cancer treatment delays in a majority minority community: is there a difference? J Oncol Pract 2015 Mar;11(2):144-153.

      Not Specified

      Lathrop KI. New Note from Copeland Edward, Chapter 79: Unknown Primary Presenting with Axillary Lymphadenopathy, Bland et al The Breast, 5th edition 2016 Jun;.

  • Clinical

    Board Certifications

    • American Board of Internal Medicine/Medical Oncology
    • American Board of Internal Medicine
map image

UT Health San Antonio

7703 Floyd Curl Drive
San Antonio, TX 78229

210-567-7000

We make lives better ©

We're a part of UT Health San Antonio, provider of comprehensive health,  dental, &  cancer care,  advanced academics,  and  life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.